![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Presidente presso
PERCHERON THERAPEUTICS LIMITED
Patrimonio netto: 5 125 $ in data 30/06/2026
Profilo
Charmaine Gittleson is Non-Executive Chairman at Percheron Therapeutics Ltd. since 2023, Independent Non-Executive Director at Polynovo Ltd. starting 2026, Non-Executive Director at George Medicines Pty Ltd., and Non-Executive Director at Imugene Ltd. starting 2026.
Former roles include Chairman at Patrys Ltd. from 2022 to 2025 and Chief Medical Officer at CSL Ltd. Education includes an undergraduate degree from the University of the Witwatersrand.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2024 | 2.464.000 ( 0,16% ) | 5 125 $ | 30/06/2026 |
Posizioni attive di Charmaine Gittleson
| Società | Posizione | Inizio |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Presidente | - |
| POLYNOVO LIMITED | Direttore/Membro del Consiglio | 01/04/2026 |
| IMUGENE LIMITED | Direttore/Membro del Consiglio | 30/06/2026 |
Precedenti posizioni note di Charmaine Gittleson
| Società | Posizione | Fine |
|---|---|---|
| PATRYS LIMITED | Presidente | 17/06/2025 |
| CSL LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Charmaine Gittleson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
